Send this to a friend

SEC charges Marlborough's Lemelson Capital with fraud

A Marlborough hedge fund adviser and his investment firm are being charged by the U.S. Securities and Exchange Commission with profiting more than $1.3 million after driving down the price of a California pharmaceutical company.
In a civil complaint filed in federal court Wednesday, the SEC charged Gregory Lemelson of Lemelson Capital Management with issuing false information about Ligand Pharmaceuticals after Lemelson took a short position in the ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media